NCT05951491

Brief Summary

The goal of this clinical trial is to compare arm and hand function with and without assistance from a wearable exoskeleton in individuals with neurological injury from a single stroke. The main questions it aims to answer are:

  • Can a portable (i.e., body-mounted) shoulder exoskeleton increase the reachable workspace of an individual after stroke?
  • Can shoulder assistance from a body-mounted exoskeleton improve hand function after stroke?
  • Does shoulder assistance from a body-mounted exoskeleton lead to changes in functional use of the impaired limb at home? Participants will perform tasks with and without assistance from a portable exoskeleton, including:
  • maximal area sweeps in each of three directional planes (sagittal, frontal, transverse).
  • simultaneous wrist and finger extension while attempting to pick up objects of varying size from the Action Research Arm Test (ARAT), Wolf Motor Function Test (WMFT), and Box and Blocks (BBT) test kits.
  • standardized clinical assessments in a laboratory setting that have been shown to correlate with functional performance of activities of daily living including WMFT, ARAT, and BBT.
  • a Motor Activity Log (MAL) based on activity performed in the past week as a baseline, before wearing the exoskeleton at home for a period of 1-2 hours per day for at least 5 days.
  • a System Usability Scale and a second MAL corresponding with the activities performed while wearing the exoskeleton during the at-home phase. Researchers will compare functional ability measures with and without wearing the portable shoulder exoskeleton to see if the assistance improves functional performance in the arm and/or hand.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
15mo left

Started Jun 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Jun 2024Aug 2027

First Submitted

Initial submission to the registry

June 15, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 19, 2023

Completed
11 months until next milestone

Study Start

First participant enrolled

June 18, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

2.9 years

First QC Date

June 15, 2023

Last Update Submit

April 28, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • BBT change in score

    Percent change in Box and Blocks Test score WITH vs. WITHOUT the assistive exoskeleton. Blocks are moved from one bin over a barrier to another bin in 1 minute. The number of blocks successfully transferred over the barrier is the score. BBT Minimum scale value = 0 (worst performance). BBT improvement = ( (score with exo) - (score without exo) ) / (score without exo) \* 100

    Scores with and without exoskeleton assistance are measured during a single session not more than 30 minutes apart.

  • ARAT change in score

    Percent change in Action Research Arm Test score WITH vs. WITHOUT the assistive exoskeleton. 19 tasks are scored on a scale from 0-3. ARAT Minimum scale value = 0 (worst performance). ARAT Maximum scale value = 57 (best performance). ARAT improvement = ( (score with exo) - (score without exo) ) / (score without exo) \* 100

    Scores with and without exoskeleton assistance are measured during a single session not more than 30 minutes apart.

Secondary Outcomes (2)

  • Unassisted Arm Use at Home (without device)

    up to 5 days

  • Unassisted Arm Use at Home (with device)

    up to 5 days

Other Outcomes (2)

  • Motor Activity Log

    up to 2 weeks

  • Range of motion change

    up to 2 weeks

Study Arms (1)

Chronic Stroke

EXPERIMENTAL

Individuals more than 6 months post-stroke in stable condition with long-term impairment affecting the arm and hand.

Device: Wearable Shoulder ExoskeletonDevice: Wearable Hand Exoskeleton

Interventions

The wearable shoulder exoskeleton prototype is under development at the University of Idaho to provide gravity support to the shoulder. Subjects will use the device at home for a period of 3-5 days for at least 2 hours per day.

Also known as: Wearable-S
Chronic Stroke

The wearable hand exoskeleton prototype is under development at the University of Idaho to provide hand-opening support. Subjects will use the device at home for a period of 3-5 days for at least 2 hours per day.

Also known as: Wearable-H
Chronic Stroke

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have arm and hand impairment resulting from a single stroke that occurred more than 6 months ago.
  • have some volitional extension of the wrist and fingers to grasp small objects and the ability to elevate the shoulder at least 15 degrees.

You may not qualify if:

  • currently pregnant
  • under 18
  • incarcerated
  • severe pain with arm or hand movement
  • inability to understand verbal or visual instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Idaho Integrated Research and Innovation Center

Moscow, Idaho, 83844, United States

Location

MeSH Terms

Conditions

Paresis

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Joel C Perry, PhD

    University of Idaho

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SEQUENTIAL
Model Details: 30 participants will enroll in a first assessment phase in a laboratory stetting comparing function with and without assistance from a wearable system. A subset of these (approximately 12) will enroll in a subsequent at-home phase.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 15, 2023

First Posted

July 19, 2023

Study Start

June 18, 2024

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

The results of the study will be presented at conferences, targeting the Annual Society of Neurorehabilitation and at the annual Mountain West Clinical \& Translational Research Infrastructure Network (MW CTR-IN) conference in Las Vegas, Nevada. We plan to disseminate the full results of the trial via appropriate peer-reviewed journals in a timely manner and make de-identified datasets available via the University of Idaho Library. The informed consent documents for the clinical trial will include a specific statement relating to posting of clinical trial information at ClinicalTrials.gov. All data from individual participants will be anonymized or provided in aggregate form prior to sharing.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be available at the conclusion of the study for at least 25 years.
Access Criteria
There will be no restrictions for access to deidentified data, both summarized and individual.
More information

Locations